Home > Insider Trading > Filing (0001348324-16-000168)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1348324	Ldr Holding Corp	LDRH	Surgical & Medical Instruments & Apparatus (3841)	203933262

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1586612	Joseph G. Ross	13785 Research Blvd., Suite 200 Austin TX 78750	Exec Vp Global Marketing	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2016-03-11	2,288	$3.11	7,520	No	4	M	Direct
Common Stock	Acquisiton	2016-03-11	10,093	$5.94	17,613	No	4	M	Direct
Common Stock	Disposition	2016-03-11	17,613	$23.07	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Incentive Stock Option (right to buy)	Disposition	2016-03-11	2,288	$0.00	2,288	$3.11
Common Stock	Incentive Stock Option (right to buy)	Disposition	2016-03-11	10,093	$0.00	10,093	$5.94

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2012-02-01	2020-11-19	No	4	M	Direct
1,176	2013-07-10	2022-07-10	No	4	M	Direct

Footnotes

Includes 394 and 306 ESPP shares acquired under the LDR Holding Corporation Amended and Restated 2013 Employee Stock Purchase Plan on May 31, 2015 and November 30, 2015 respectively. Also includes 842 RSU shares acquired on 1/1/16, 1,263 RSU shares acquired on 1/16/16, and 2,427 Performance RSU shares acquired on 2/15/16.
The price indicated is the weighted average sale price for the shares sold. The individual sale price for the shares indicated range from $22.87 to $23.24. The reporting person undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, further information regarding the number of shares sold at each separate price such shares were sold.
ISO becomes exercisable in combination with NQSO granted on the same date wherein the shares vest in forty-eight equal monthly installments from the vesting commencement date of January 1, 2012.
ISO becomes exercisable in combination with NQSO granted on the same date wherein 25% of the shares granted become exercisable upon one year from the vesting commencement date of July 10, 2012, then in thirty-six equal monthly installments thereafter.